Chemotherapy of Diffuse Astrocytoma (WHO grade II) in Adults.
Chemotherapy of Diffuse Astrocytoma (WHO grade II) in Adults.
Prog Neurol Surg. 2018;31:145-151
Authors: Narita Y
Abstract
The effectiveness of chemotherapy or chemoradiotherapy for diffuse astrocytoma (DA) has been largely unknown until recently. However, a randomized controlled study (RTOG 9802) showed that adding of procarbazine, CCNU, and vincristine (PCV) chemotherapy to fractionated radiotherapy (FRT) in patients with "high-risk" WHO grade II gliomas, including DA, has significant positive impact on both progression-free survival and overall survival. Effectiveness of temozolomide (TMZ) in cases of low-grade gliomas was also reported, and a randomized phase III trial comparing FRT alone or in combination with TMZ in cases of unresectable DA (JCOG 1303) is currently ongoing.
PMID: 29393182 [PubMed - in process]
Source: Progress in Neurological Surgery - Category: Neurosurgery Tags: Prog Neurol Surg Source Type: research
More News: Astrocytoma | Brain | Brain Tumor | Chemotherapy | Glioma | Neurology | Neurosurgery | Study | Temodar